Xiang Cheng

24PUBLICATIONS
115CO-AUTHORS
Molecular targetsCardiology (incl. cardiovascular diseases)Traditional Chinese medicine and treatmentsCharacterisation of biological macromoleculesHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jun 17, 2026
Intermediate accumulated upon interruption of fatty acid oxidation flux promotes tumoral ferroptosis and improves immunotherapy.

|May 25, 2026
Long-Term Efficacy and Safety of Mavacamten in Chinese Patients With Obstructive Hypertrophic Cardiomyopathy: Week 78 Results From the EXPLORER-CN Study.

|May 21, 2026
Mavacamten in Chinese Patients with Obstructive Hypertrophic Cardiomyopathy: Patient-Reported Health Status Analysis up to 78 Weeks in the EXPLORER-CN Study.

|Apr 27, 2026
Mechanisms and therapeutic potential of colchicine in atherosclerotic cardiovascular disease.

|Apr 21, 2026
TMEM87A suppresses ferroptosis and increases cancer immunotherapy resistance by maintaining the Golgi apparatus pH homeostasis.

|Apr 07, 2026
Prognostic Value of Angiographic Microcirculatory Resistance After Coronary Intervention: Insights From the FAVOR III China Trial.

Hongliang Zhang, Wence Shi, Zhenyan Zhao

Pageof 4

Frequent Collaborators

4 joint publications

Weimin Wang

3 joint publications

Bo Yu

3 joint publications

Jian'an Wang

3 joint publications

Chen Chen